Type I interferons and TGF-β cooperate to induce liver fibrosis during HIV-1 infection under antiretroviral therapy
Liver diseases have become a major comorbidity health concern for people living with HIV-1 (PLWH) treated with combination antiretroviral therapy (cART). To investigate if HIV-1 infection and cART interact to lead to liver diseases, humanized mice reconstituted with progenitor cells from human fetal...
Main Authors: | James Ahodantin, Kouki Nio, Masaya Funaki, Xuguang Zhai, Eleanor Wilson, Shyamasundaran Kottilil, Liang Cheng, Guangming Li, Lishan Su |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical investigation
2022-07-01
|
Series: | JCI Insight |
Subjects: | |
Online Access: | https://doi.org/10.1172/jci.insight.152738 |
Similar Items
-
Blockade of TGF-β signaling reactivates HIV-1/SIV reservoirs and immune responses in vivo
by: Sadia Samer, et al.
Published: (2023-06-01) -
Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapy
by: Yuyang Tang, et al.
Published: (2023-06-01) -
Guidelines for antiretroviral therapy in adults
by: G Meintjes, et al.
Published: (2012-08-01) -
Rapamycin limits CD4+ T cell proliferation in simian immunodeficiency virus–infected rhesus macaques on antiretroviral therapy
by: Benjamin D. Varco-Merth, et al.
Published: (2022-05-01) -
The mechanism of action of iminosugars as antiretrovirals
by: Spiro, S, et al.
Published: (2014)